메뉴 건너뛰기




Volumn 120, Issue 2, 1996, Pages 174-181

Active immunotherapy of pancreatic cancer with tumor cells genetically engineered to secrete multiple cytokines

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; KANAMYCIN KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

EID: 0029737924     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0039-6060(96)80285-6     Document Type: Article
Times cited : (25)

References (18)
  • 2
    • 0027502562 scopus 로고
    • Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells
    • Connor J Bannerji R Saito S Heston W Fair W Gilboa E Regression of bladder tumors in mice treated with interleukin-2 gene-modified tumor cells J Exp Med 177 1993 1127 1134
    • (1993) J Exp Med , vol.177 , pp. 1127-1134
    • Connor, J1    Bannerji, R2    Saito, S3    Heston, W4    Fair, W5    Gilboa, E6
  • 3
    • 0027538181 scopus 로고
    • Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
    • Dranoff G Jaffee E Lazenby A Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity Proc Natl Acad Sci USA 90 1993 3539 3543
    • (1993) , pp. 3539-3543
    • Dranoff, G1    Jaffee, E2    Lazenby, A3
  • 4
    • 0025000864 scopus 로고
    • Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
    • Gansbacher B Zier K Daiels B Cronin K Bannerji R Gilboa E Interleukin-2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity J Exp Med 172 1990 1217 1224
    • (1990) J Exp Med , vol.172 , pp. 1217-1224
    • Gansbacher, B1    Zier, K2    Daiels, B3    Cronin, K4    Bannerji, R5    Gilboa, E6
  • 5
    • 0026331269 scopus 로고
    • Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4
    • Golumbek P Lazenby A Levitsky H Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4 Science 254 1991 713 716
    • (1991) Science , vol.254 , pp. 713-716
    • Golumbek, P1    Lazenby, A2    Levitsky, H3
  • 6
    • 0027373477 scopus 로고
    • Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-g genes
    • Porgador A Tzehoval E Vadai E Feldman M Eisenbach L Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-g genes J Immunother 14 1993 191 201
    • (1993) J Immunother , vol.14 , pp. 191-201
    • Porgador, A1    Tzehoval, E2    Vadai, E3    Feldman, M4    Eisenbach, L5
  • 7
    • 0028342391 scopus 로고
    • Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines
    • Saito S Bannerji R Gansbacher B Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines Cancer Res 54 1994 3516 3520
    • (1994) Cancer Res , vol.54 , pp. 3516-3520
    • Saito, S1    Bannerji, R2    Gansbacher, B3
  • 8
    • 0028342391 scopus 로고
    • Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines
    • Vieweg J Rosenthal R Bannerji R Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines Cancer Res 54 1994 3516 3520
    • (1994) Cancer Res , vol.54 , pp. 3516-3520
    • Vieweg, J1    Rosenthal, R2    Bannerji, R3
  • 9
    • 0021330445 scopus 로고
    • Induction and chemo-therapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice
    • Corbett T Roberts B Liopold W Induction and chemo-therapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL/6 mice Cancer Res 44 1984 717 726
    • (1984) Cancer Res , vol.44 , pp. 717-726
    • Corbett, T1    Roberts, B2    Liopold, W3
  • 10
    • 0030052945 scopus 로고    scopus 로고
    • Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer
    • Philip R Clary B Brunette E Gene modification of primary tumor cells for active immunotherapy of human breast and ovarian cancer Clin Cancer Res 2 1996 59 68
    • (1996) Clin Cancer Res , vol.2 , pp. 59-68
    • Philip, R1    Clary, B2    Brunette, E3
  • 11
    • 0025604195 scopus 로고
    • Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity
    • Gansbacher B Bannerji R Daniels B Zier K Cronin K Gilboa E Retroviral vector-mediated γ-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity Cancer Res 50 1990 7820 7825
    • (1990) Cancer Res , vol.50 , pp. 7820-7825
    • Gansbacher, B1    Bannerji, R2    Daniels, B3    Zier, K4    Cronin, K5    Gilboa, E6
  • 12
    • 0029057646 scopus 로고
    • Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer
    • Vieweg J Boczkowski D Robertson K Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer Cancer Res 55 1995 2366 2372
    • (1995) Cancer Res , vol.55 , pp. 2366-2372
    • Vieweg, J1    Boczkowski, D2    Robertson, K3
  • 13
    • 0027298471 scopus 로고
    • Anti-metastatic vaccination of tumor-bearing mice with two types of gamma-interferon gene inserted tumor cells
    • Porgador A Bannerji R Watanabew Y Feldman M Gilboa E Eisenbach L Anti-metastatic vaccination of tumor-bearing mice with two types of gamma-interferon gene inserted tumor cells J Immunol 150 1993 1458 1463
    • (1993) J Immunol , vol.150 , pp. 1458-1463
    • Porgador, A1    Bannerji, R2    Watanabew, Y3    Feldman, M4    Gilboa, E5    Eisenbach, L6
  • 14
    • 0020173287 scopus 로고
    • Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis
    • Van Pel A Boon T Protection against a nonimmunogenic mouse leukemia by an immunogenic variant obtained by mutagenesis Proc Natl Acad Sci USA 79 1982 4718 4722
    • (1982) , pp. 4718-4722
    • Van Pel, A1    Boon, T2
  • 15
    • 0027370675 scopus 로고
    • Tumor-rejection antigens recognized by T-lymphocytes
    • Finn O Tumor-rejection antigens recognized by T-lymphocytes Curr Opin Immunol 5 1993 701 708
    • (1993) Curr Opin Immunol , vol.5 , pp. 701-708
    • Finn, O1
  • 16
    • 0025882042 scopus 로고
    • T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes
    • Peace D Smith J Disis M Cheever M T cell recognition of transforming proteins encoded by mutated ras proto-oncogenes J Immunol 146 1991 2059 2065
    • (1991) J Immunol , vol.146 , pp. 2059-2065
    • Peace, D1    Smith, J2    Disis, M3    Cheever, M4
  • 17
    • 0028270141 scopus 로고
    • The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity
    • Bannerji R Arroyo C Cordon-Cardo C Gilboa E The role of IL-2 secreted from genetically modified tumor cells in the establishment of antitumor immunity J Immunol 152 1994 2324 2331
    • (1994) J Immunol , vol.152 , pp. 2324-2331
    • Bannerji, R1    Arroyo, C2    Cordon-Cardo, C3    Gilboa, E4
  • 18
    • 0027392843 scopus 로고
    • Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells
    • Townsend S Allison J Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells Science 259 1993 368 370
    • (1993) Science , vol.259 , pp. 368-370
    • Townsend, S1    Allison, J2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.